Question:

When is it appropriate to assign modifier JF with codes for drugs?

Answer:

In the July update to the outpatient prospective payment system (OPPS), the Centers for Medicare & Medicaid Services (CMS) included instructions for the following level II code, which took effect on July 1. 

Q9977 Compounded drug, not otherwise classified

In the October OPPS update, CMS noted that this code replaces the use of modifier JF (compounded drug), which has been discontinued. HCPCS code Q9977 should be used to report compounded drug combinations. 

The October update can be found at https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/Downloads/MM9298.pdf

Facebook
Twitter
LinkedIn
Email
Print

CPT® copyright 2021 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.